tiprankstipranks
Trending News
More News >
Abbvie (DE:4AB)
:4AB
Germany Market

AbbVie (4AB) Technical Analysis

Compare
20 Followers

Summary of all the Indicators

Overall Consensus
Strong Sell
0Bullish
0Neutral
13Bearish
Technical Analysis Consensus
Strong Sell
0Bullish
0Neutral
1Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Abbvie’s (4AB) Moving Averages Convergence Divergence (MACD) indicator is 0.34, suggesting Abbvie is a Buy.
Abbvie’s (4AB) 20-Day exponential moving average is 185.92, while Abbvie’s (4AB) share price is €167.2, making it a Sell.
Abbvie’s (4AB) 50-Day exponential moving average is 186.04, while Abbvie’s (4AB) share price is €167.2, making it a Sell.

AbbVie (4AB) Pivot Points

Apr 09, 2025, 07:38 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
185.63
187.31
190.29
191.97
194.95
196.63
199.61
Fibonacci
187.31
189.09
190.19
191.97
193.75
194.85
196.63
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

AbbVie (4AB) Moving Averages

Apr 09, 2025, 07:38 PM
Period
Simple
Exponential
MA5
177.40Sell
175.57Sell
MA10
183.70Sell
181.25Sell
MA20
188.93Sell
185.92Sell
MA50
189.05Sell
186.04Sell
MA100
177.96Sell
181.21Sell
MA200
173.59Sell
173.37Sell
Abbvie’s (4AB) 10-Day exponential moving average is 181.25, while Abbvie’s (4AB) share price is €167.2, making it a Sell.
Abbvie’s (4AB) 100-Day exponential moving average is 181.21, while Abbvie’s (4AB) share price is €167.2, making it a Sell.
Abbvie’s (4AB) stock price is €167.2 and Abbvie’s (4AB) 50-day simple moving average is 189.05, creating a Sell signal.
Abbvie’s (4AB) stock price is €167.2 and Abbvie’s (4AB) 100-day simple moving average is 177.96, creating a Sell signal.
Abbvie’s (4AB) stock price is €167.2 and Abbvie’s (4AB) 200-day simple moving average is 173.59, creating a Sell signal.

AbbVie (4AB) Technical Indicators

Apr 09, 2025, 07:38 PM
Name
Value
Implied Action
RSI (14)
55.77
Neutral
STOCH (9,6)
63.78
Neutral
STOCHRSI (14)
58.59
Neutral
MACD (12,26)
0.34
Buy
ADX (14)
23.22
Neutral
Williams %R
-20.86
Buy
CCI (14)
26.31
Neutral
ATR (14)
3.45
-
Ultimate Oscillator
50.80
Neutral
ROC
-13.35
Sell
Abbvie’s (4AB) Relative Strength Index (RSI) is 55.77, creating a Neutral signal.
Abbvie’s (4AB) Trend Strength Indicator (ADX) is 23.22, creating a Neutral signal.
Abbvie’s (4AB) Commodity Channel Index (CCI) is 26.31, creating a Neutral signal.
Abbvie’s (4AB) Price Rate of Change (ROC) is -13.35, creating a Sell signal.

FAQ

Is 4AB a Buy, Hold, or Sell?
Based on 4AB’s technical indicators, 4AB is a Strong Sell.
    What is 4AB’s RSI (14)?
    4AB’s RSI (14) is 55.77, which suggests 4AB is a Neutral.
      What is 4AB’s MACD?
      4AB’s MACD is 0.34, which suggests 4AB is a Buy.
        What is 4AB’s 5-day moving average?
        4AB’s 5-day moving average is 177.40, which suggests 4AB is a Sell.
          What is 4AB’s 20-day moving average?
          4AB 20-day moving average is 188.93, which suggests 4AB is a Sell.
            What is 4AB’s 50-day moving average?
            4AB’s 50-day moving average is 189.05, which suggests 4AB is a Sell.
              What is 4AB’s 200-day moving average?
              4AB’s 200-day moving average is 173.59, which suggests 4AB is a Sell.
                What is 4AB’s Williams % R (14)?
                4AB’s Williams % R (14) is -20.86, which suggests 4AB is a Buy.
                  What is 4AB’s CCI (14)?
                  4AB’s CCI (14) is 26.31, which suggests 4AB is a Neutral.
                    What is the share price of Abbvie?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis